Connor MSc - Bionomics VP Devel
| BNOXDelisted Stock | USD 4.88 0.07 1.41% |
Insider
Connor MSc is VP Devel of Bionomics Ltd ADR
| Age | 36 |
| Phone | 61 8 8150 7400 |
| Web | https://www.bionomics.com.au |
Bionomics Management Efficiency
The company has return on total asset (ROA) of (0.3958) % which means that it has lost $0.3958 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7844) %, meaning that it created substantial loss on money invested by shareholders. Bionomics' management efficiency ratios could be used to measure how well Bionomics manages its routine affairs as well as how well it operates its assets and liabilities.Bionomics Ltd ADR currently holds 272.74 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Bionomics ADR has a current ratio of 12.21, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Bionomics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| MD FACP | AN2 Therapeutics | 77 | |
| Timothy MBA | Aerovate Therapeutics | 63 | |
| Fangyong Du | Adagene | 54 | |
| Oz CPA | Scisparc | 38 | |
| Eric Devroe | Acrivon Therapeutics, Common | 46 | |
| LLM JD | Rezolute | 63 | |
| Rasmus HolmJorgensen | Acrivon Therapeutics, Common | 53 | |
| Scott Anderson | Anebulo Pharmaceuticals | N/A | |
| Winston MBA | Pmv Pharmaceuticals | 48 | |
| Leila MD | Pmv Pharmaceuticals | 61 | |
| Timothy Pigot | Aerovate Therapeutics | 53 | |
| Josh Eizen | AN2 Therapeutics | N/A | |
| Crystal Mercado | Acrivon Therapeutics, Common | N/A | |
| Jeff Fensterer | Accustem Sciences | 44 | |
| Sanjay Chanda | AN2 Therapeutics | 60 | |
| Joe Flanagan | Accustem Sciences | 49 | |
| Benjamin Dake | Aerovate Therapeutics | 49 | |
| Rex CFA | Anebulo Pharmaceuticals | 64 | |
| Guizhong Liu | Adagene | 54 | |
| Kenneth Cundy | Anebulo Pharmaceuticals | 66 | |
| Thomas Shenk | Pmv Pharmaceuticals | 77 | |
Management Performance
| Return On Equity | -0.78 | |||
| Return On Asset | -0.4 |
Bionomics ADR Leadership Team
Elected by the shareholders, the Bionomics' board of directors comprises two types of representatives: Bionomics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bionomics. The board's role is to monitor Bionomics' management team and ensure that shareholders' interests are well served. Bionomics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bionomics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Spyridon MD, President CEO | ||
| Elizabeth Doolin, Senior Development | ||
| DCPSA FFPM, Consultant Neuroscience | ||
| Errol Souza, Ex Chairman | ||
| FCA BEC, Financial Controller | ||
| FCIS BCom, Company Secretary | ||
| MD DFAPA, Acting Officer | ||
| Julie Kerner, Senior Operations | ||
| Connor MSc, VP Devel |
Bionomics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bionomics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.78 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | 89.10 % | |||
| Current Valuation | 14.16 B | |||
| Shares Outstanding | 1.63 M | |||
| Shares Owned By Insiders | 33.91 % | |||
| Shares Owned By Institutions | 16.22 % | |||
| Number Of Shares Shorted | 400.4 K | |||
| Price To Book | 829.81 X | |||
| Price To Sales | 386.72 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Bionomics Stock
If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |